In a move to address the growing demand for sustainable and high-performance ingredients, Manus, the proven bioalternatives scale-up platform, today announced the opening of its new, purpose-built application hub in Singapore. The state-of-the-art Singapore BioFacility is now fully operational, serving as a regional center to support customers and partners across the entire Asia-Pacific region.

‍

This expansion directly responds to the critical needs of a market facing volatile agricultural supply chains and a strong consumer shift towards natural and clean-label products. Singapore's unique position as a hub for innovation, with its exceptional regional connectivity and deep technical talent, provides the ideal ecosystem.

‍

The new facility is designed to be a center for direct partnership. Its primary function is to help customers bring advanced bioalternatives to market through hands-on product development, formulation optimization, and application-focused problem-solving tailored to local needs.

‍

“In our application lab, teams will work side by side with customers to test, refine, and adapt formulations to regional requirements, performance expectations, and end-use applications before scaling,” states Gary Tan, Vice President, Global Food Ingredients – Application and Customer Technical Services.“ This hands-on approach helps ensure Manus products perform as intended in real-world applications.”

‍

This collaborative model provides partners with a low-risk pathway to integrate advanced biobased solutions, significantly accelerating their time-to-market. The precision of biomanufacturing offers an unparalleled level of quality and consistency assurance, giving industry leaders greater control over their essential ingredients and derisking their operations.

‍

The proven bioalternatives scale-up platform

The Singapore BioFacility is the latest proof point of Manus’ proven, end-to-end biomanufacturing platform. It will serve as a crucial bridge connecting the company's cutting-edge R&D and innovation hubs in Boston, Massachusetts, and Pleasanton, California, with its large-scale bioalternatives production facility in Augusta, Georgia.

‍

By establishing a local presence, Manus is offering industry leaders a direct pathway to build smarter, more agile, and sustainable products. The company invites companies across the Asia-Pacific region to connect and explore how its products and collaborative approach can help them realize the benefits of biomanufacturing, today.